Insulet (PODD) EPS (Weighted Average and Diluted) (2016 - 2025)
Insulet (PODD) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with $1.43 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 3.62% year-over-year to $1.43, compared with a TTM value of $3.48 through Dec 2025, down 39.79%, and an annual FY2025 reading of $3.48, down 39.79% over the prior year.
- EPS (Weighted Average and Diluted) was $1.43 for Q4 2025 at Insulet, up from $1.23 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $2.59 in Q2 2024 and bottomed at -$0.5 in Q2 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.66, with a median of $0.44 recorded in 2021.
- The sharpest move saw EPS (Weighted Average and Diluted) crashed 272.73% in 2021, then skyrocketed 1025.0% in 2023.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.44 in 2021, then tumbled by 43.18% to $0.25 in 2022, then surged by 488.0% to $1.47 in 2023, then dropped by 6.12% to $1.38 in 2024, then rose by 3.62% to $1.43 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for PODD at $1.43 in Q4 2025, $1.23 in Q3 2025, and $0.32 in Q2 2025.